Form 4 for LH Labcorp
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-07 · accession 0001127602-24-009301 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-11 | 2024-03-07 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | S - Sale+OE | $218.45 | -5,048 | 5,036 | -50% | -$1.10M |
| D | 2024-03-11 | 2024-03-07 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | $117.09 | +2,119 | 10.1K | +27% | +$248.1K |
| D | 2024-03-11 | 2024-03-07 | LH | Schroeder Mark S | EVP, COO, Pres Diagnostics | M - OptEx | $0.00 | -2,119 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-07 | S | D | 5,048 | $218.45 | 5,036.14 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-07 | M | A | 2,119 | $117.09 | 10,084.14 | D | — | — | |
| 3 | Derivative | Non-qualified Stock Options | 2024-03-07 | M | D | 2,119 | $0.00 | 0 | D | $117.09 · 2018-02-07 to 2027-02-06 | 2,119 Common Stock | (F2) Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. (F3) Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea. (F4) The option vested in three equal annual installments beginning on the date reflected in this column. |